Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1105528.RAts1vu-EF2Q8Scap1U730Z9Xam0d-NHe7C5XhBakTCe0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1105528.RAts1vu-EF2Q8Scap1U730Z9Xam0d-NHe7C5XhBakTCe0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1105528.RAts1vu-EF2Q8Scap1U730Z9Xam0d-NHe7C5XhBakTCe0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1105528.RAts1vu-EF2Q8Scap1U730Z9Xam0d-NHe7C5XhBakTCe0130_provenance.
- NP1105528.RAts1vu-EF2Q8Scap1U730Z9Xam0d-NHe7C5XhBakTCe0130_assertion description "[Mechanistically, CXCR7-targeting Nanobodies did not inhibit cell cycle progression but instead reduced secretion of the angiogenic chemokine CXCL1 from head and neck cancer cells in vitro, thus acting here as inverse agonists, and subsequent angiogenesis in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1105528.RAts1vu-EF2Q8Scap1U730Z9Xam0d-NHe7C5XhBakTCe0130_provenance.
- NP1105528.RAts1vu-EF2Q8Scap1U730Z9Xam0d-NHe7C5XhBakTCe0130_assertion evidence source_evidence_literature NP1105528.RAts1vu-EF2Q8Scap1U730Z9Xam0d-NHe7C5XhBakTCe0130_provenance.
- NP1105528.RAts1vu-EF2Q8Scap1U730Z9Xam0d-NHe7C5XhBakTCe0130_assertion SIO_000772 23979133 NP1105528.RAts1vu-EF2Q8Scap1U730Z9Xam0d-NHe7C5XhBakTCe0130_provenance.
- NP1105528.RAts1vu-EF2Q8Scap1U730Z9Xam0d-NHe7C5XhBakTCe0130_assertion wasDerivedFrom befree-2016 NP1105528.RAts1vu-EF2Q8Scap1U730Z9Xam0d-NHe7C5XhBakTCe0130_provenance.
- NP1105528.RAts1vu-EF2Q8Scap1U730Z9Xam0d-NHe7C5XhBakTCe0130_assertion wasGeneratedBy ECO_0000203 NP1105528.RAts1vu-EF2Q8Scap1U730Z9Xam0d-NHe7C5XhBakTCe0130_provenance.
- befree-2016 importedOn "2016-02-19" NP1105528.RAts1vu-EF2Q8Scap1U730Z9Xam0d-NHe7C5XhBakTCe0130_provenance.